Antisense inhibition of PKA regulatory subunit RII alpha expression
US6524854B1 · kind B1 · utility
91Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2001 |
| Grant date | Feb 25, 2003 |
| Priority date | — |
| Expiry date | Sep 25, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of PKA regulatory subunit RII alpha. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PKA regulatory subunit RII alpha. Methods of using these compounds for modulation of PKA regulatory subunit RII alpha expression and for treatment of diseases associated with expression of PKA regulatory subunit RII alpha are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.